Carmela Gnerre

Inhibition of Monoamine Oxidases by Functionalized Coumarin Derivatives:  Biological Activities, QSARs, and 3D-QSARs

Carmela Gnerre, Marco Catto, Francesco Leonetti et al. · Journal of Medicinal Chemistry · 2000 · 261 citations · Full text

Regulation of CYP3A4 by the bile acid receptor FXR

Carmela Gnerre, Sharon Bl ttler, Michel Kaufmann et al. · Pharmacogenetics · 2004 · 163 citations

Toxicological Mechanism, Oxidative Stress, Molecular Pharmacology +17

Natural and Synthetic Xanthones as Monoamine Oxidase Inhibitors: Biological Assay and 3D-QSAR

Carmela Gnerre, Ulrike Thull, Patrick Gaillard et al. · Helvetica Chimica Acta · 2001 · 78 citations

Medicinal Chemistry, Biochemistry, Monoamine Oxidase Inhibitors +14

Lipophilicity Plays a Major Role in Modulating the Inhibition of Monoamine Oxidase B by 7‐Substituted Coumarins

Angelo Carotti, Cosimo Altomare, Marco Catto et al. · Chemistry & Biodiversity · 2006 · 55 citations

Pharmacotherapy, Pharmaceutical Chemistry, Oxidative Stress +17

4-((<i>R</i>)-2-{[6-((<i>S</i>)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl]amino}-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and Its Prodrug (ACT-281959), a Novel P2Y₁₂ Receptor Antagonist with a Wider Therapeutic Window in the Rat Than Clopidogrel

Eva Caroff, Francis Hubler, Emmanuel A. Meyer et al. · Journal of Medicinal Chemistry · 2015 · 50 citations

Disease-relevant Platelet Aggregation, Pharmacotherapy, Experimental Pharmacology +20